Today's Stock Analyst Downgrades

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AARD Aardvark Therapeutics	Downgraded by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeet Mukherjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.57 -32.1%		Buy ➝ Hold
AEG Aegon	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.39 +0.2%		Overweight ➝ Equal Weight
ALMS Alumis	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.87 -7.1%	$25.00	Buy ➝ Neutral
BLX Boralex	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$36.86 +0.1%	C$38.00 ➝ C$37.25	Outperform ➝ Market Perform
CARD Card Factory	Downgraded by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 67.40 -1.9%	GBX 110 ➝ GBX 80	Hold
CARE Carter Bankshares	Downgraded by	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$26.21 -3.2%		Strong-Buy ➝ Hold
CCAP Crescent Capital BDC	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchel Penn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.13 -7.2%	$19.00 ➝ $16.00	Outperform ➝ Market Perform
ECO Okeanis Eco Tankers	Downgraded by	Clarkson Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.03 +0.8%		Strong-Buy ➝ Hold
FRMI Fermi	Downgraded by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.51 -11.7%	$11.00	Outperform ➝ In-Line
GSAT Globalstar	Downgraded by	Clear Str Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.98 -0.1%		Strong-Buy ➝ Hold
Read this or regret it forever (Ad) Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. Don’t be left behind. Click here now.
JSPR Jasper Therapeutics	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yaron Werber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.85 -11.4%		Buy ➝ Hold
KSS Kohl's	Downgraded by	Gordon Haskett Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.78 -1.3%	$14.00	Buy ➝ Hold
LSTA Lisata Therapeutics	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.17 +2.9%		Buy ➝ Neutral
NEUP Neuphoria Therapeutics	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.73 -7.1%		Buy ➝ Neutral
OPTU Optimum Communications	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.81 -7.5%	$1.50 ➝ $0.50	Neutral ➝ Sell
PRV.UN PRO Real Estate Investment Trust	Downgraded by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.30 +0.4%	C$6.75 ➝ C$7.00	Outperformer ➝ Neutral
STNE StoneCo	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gustavo Schroden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.61 -0.9%	$18.00 ➝ $11.00	Buy ➝ Neutral
VCT Victrex	Downgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 581 -2.8%	GBX 725 ➝ GBX 725	Buy
WDAY Workday	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$125.01 +5.3%		Market Perform ➝ Negative

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:14 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Downgrades

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Downgrades

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools